The U.S. Department of Energy (DOE), through its through its Division of Transport and Storage, has released a new Notice of Funding Opportunity titled “Advancing Oil and Natural Gas Production and Delivery” (DE-FOA-0003634). DOE plans to invest approximately $65.5 million in federal funding, paired with at least $16.4 million in required cost share, for a total of […]
The U.S. Department of Energy (DOE), Office of Critical Minerals and Energy Innovation (CMEI), through the Alternative Fuels and Feedstocks Office (AFFO), has issued a Notice of Intent (NOI) for a forthcoming funding opportunity titled “Accelerating Scale-up and Pre-piloting of Emerging Chemical Technologies (ASPECT)” (DE-FOA-0003646). DOE anticipates releasing the full Notice of Funding Opportunity (NOFO) on
DOE Signals $58 Million ASPECT Funding Opportunity for Emerging Chemical Technologies Read More »
The Advanced Research Projects Agency for Health (ARPA‑H) is launching the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program to tackle a critical, often invisible problem in the U.S. healthcare system: substandard and contaminated medicines slipping through the supply chain. Drug-related morbidity and mortality cost the system an estimated $528 billion per year and recalls affect the
Coming Soon From ARPA-H: FASTPASS For Rapid Screening of Medicines Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice titled “Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic Injuries” (BARDA-CBRN-07282026) to identify commercially available or near commercial technologies that address large-area skin loss from burns and traumatic injuries in a mass casualty setting. This notice is for
BARDA Seeks Advanced Dermal Regeneration Solutions for Severe Burns Read More »
The U.S. Department of Energy’s (DOE) inaugural Genesis Mission Summit brought leaders from government, research institutions, national laboratories, and industry to Washington, DC to set the direction for “AI for Science” as a national priority. Held on July 22, 2026, at the Capital Hilton, the summit confirmed that Genesis has moved well past its November 2025 Executive Order origins.
Inside the Genesis Mission Summit: The AI-for-Science Platform and the Funding Behind It Read More »
The Defense Advanced Research Projects Agency (DARPA) has issued a Special Notice for a new Defense Sciences Office (DSO) program, Protein ENGineering (PENG), and is hosting a hybrid Proposers Day on August 10, 2026, in Arlington, VA, with a webcast option for virtual attendees. DARPA expects to publish the full program solicitation by the end
DARPA Announces PENG Program for Programmable Protein Engineering Read More »
The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑156 under its Proactive Health Office (PHO), focusing on early clinical development of ibogaine for opioid use disorder (OUD). This Special Notice sits under ARPA‑H’s Proactive Health Office Innovative Solutions Opening (ISO PHO‑SOL‑24‑106), which is an open solicitation for “revolutionary solutions” that do not
ARPA-H’s Special Notice Supports Executive Order on Serious Mental Illness and OUD Read More »
The Defense Advanced Research Projects Agency (DARPA) Perrseus program is now live with a formal solicitation, moving from concept to concrete timelines and technical expectations. The goal hasn’t changed: build manufacturable, microscale ultra‑high‑vacuum (µUHV) packages that can support next‑generation quantum, MEMS, and photonics‑based sensors without relying on room‑sized vacuum systems. With the solicitation out, teams
DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors Read More »
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released RFI DARPA‑SN‑26‑100 on “Multiscale Reasoning for Human Physiology.” The agency is seeking input from organizations that can connect human biology from molecules to clinical outcomes in support of military medicine. The focus is on prediction, diagnosis, intervention, and recovery in
New DARPA RFI: Multiscale Reasoning Across Human Physiology Read More »
The Defense Threat Reduction Agency (DTRA), under the Department of Defense, has updated its FY2022–2026 Chemical / Biological Technologies Broad Agency Announcement (BAA HDTRA122S0002) with Topic Call 7, adding two new applied research topics in biological threat detection. The BAA is an open, five-year contracting vehicle focused on Technology Readiness Level (TRL) 3–6 technologies, meaning
DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection Read More »
Overview of the Opportunity The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Information (RFI) titled “Biosafety Level 4 Preclinical and Nonclinical Support for Medical Countermeasure Development (BSL4)”. Issued July 9, 2026, the RFI is a market research exercise to map out who can deliver preclinical and nonclinical
BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services Read More »
Overview of the Opportunity The National Institute of Allergy and Infectious Diseases (NIAID), through the National Institutes of Health (NIH), has issued RFP No. BAA-75N93026R00008 for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc‑TB), a five‑year contract program that renews the effort to accelerate TB vaccine development. The goal is to define tissue‑specific and
NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development Read More »
